Olive oil’s secret weapon against Alzheimer’s: phenolic compounds

Over three decades of in­vest­ing, Luke Evnin has backed and ad­vised dozens of biotechs de­vel­op­ing med­i­cines. Now, the long­time VC is turn­ing his know-how and

What hap­pened to Pfiz­er? In 2022, the com­pa­ny made Big Phar­ma his­to­ry: break­ing $100 bil­lion in rev­enue, thanks to its Covid-19 block­busters. CEO Al­bert Bourla